Specific binding studies indicate that silent agonists stabilize certain receptor conformations favorable for interaction with endogenous neurotransmitters, potentially leading to more nuanced control of receptor activity [79, 80]
By targeting both structural proteins (collagen and elastin) and cellular energy systems (mitochondrial function), we can achieve unprecedented results in skin rejuvenation and overall aesthetic enhancement
For most therapies, yes
In addition to biocompatibility, biodegradation, bioadhesiveness, and biofunctionality of the NDBs, several drawbacks must be addressed, such as low stability, low melting point, high surface tension, structural complexity, and well-known immunological response from organisms (Ige et al., 2012